NasdaqGS - Delayed Quote USD
Ventyx Biosciences, Inc. (VTYX)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 5:21 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUSTER MARTIN Chief Financial Officer | Sale | Apr 2, 2024 | 24,303 |
| GUJRATHI SHEILA Director | Sale | Mar 30, 2023 | 0 |
| KRUEGER CHRISTOPHER W Officer | Sale | Apr 2, 2024 | 284,999 |
| MOHAN RAJU Chief Executive Officer | Conversion of Exercise of derivative security | Jun 10, 2024 | 1,675,030 |
| NSV INVESTMENTS I, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 7, 2022 | -- |
| NSV PARTNERS III LP Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 9, 2023 | -- |
| NUSS JOHN M. PH.D. Officer | Sale | Apr 2, 2024 | 264,998 |
| SANDBORN WILLIAM J President | Sale | Aug 31, 2023 | 72,583 |
| SUBRAMANIAM SOMU Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 9, 2023 | -- |
| WHITE WILLIAM RICHARD Director | Sale | Jan 23, 2023 | 0 |
Related Tickers
ASMB Assembly Biosciences, Inc.
16.59
-9.05%
GLTO Galecto, Inc.
7.03
-1.26%
SPRO Spero Therapeutics, Inc.
1.2800
0.00%
AMLX Amylyx Pharmaceuticals, Inc.
4.6600
-2.51%
KZR Kezar Life Sciences, Inc.
0.7923
-3.82%
CTMX CytomX Therapeutics, Inc.
1.1600
-1.69%
OKUR OnKure Therapeutics, Inc.
18.55
+0.22%
HLVX HilleVax, Inc.
1.8300
-2.66%
SEER Seer, Inc.
1.9100
-1.04%
ANTX AN2 Therapeutics, Inc.
1.0800
+2.86%